Your browser doesn't support javascript.
loading
Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathway.
Althaus, Jonas; Nilius-Eliliwi, Verena; Maghnouj, Abdelouahid; Döring, Sascha; Schroers, Roland; Hudecek, Michael; Hahn, Stephan A; Mika, Thomas.
Afiliación
  • Althaus J; Department of Molecular Gastrointestinal Oncology, Ruhr University Bochum, Bochum, Germany.
  • Nilius-Eliliwi V; Department of Molecular Gastrointestinal Oncology, Ruhr University Bochum, Bochum, Germany.
  • Maghnouj A; Department of Medicine, Hematology and Oncology, Knappschaftskrankenhaus Bochum, Ruhr University Bochum, In der Schornau 23-25, D-44892, Bochum, Germany.
  • Döring S; Department of Molecular Gastrointestinal Oncology, Ruhr University Bochum, Bochum, Germany.
  • Schroers R; Department of Molecular Gastrointestinal Oncology, Ruhr University Bochum, Bochum, Germany.
  • Hudecek M; Department of Medicine, Hematology and Oncology, Knappschaftskrankenhaus Bochum, Ruhr University Bochum, In der Schornau 23-25, D-44892, Bochum, Germany.
  • Hahn SA; Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany.
  • Mika T; Department of Molecular Gastrointestinal Oncology, Ruhr University Bochum, Bochum, Germany.
Cancer Immunol Immunother ; 72(8): 2573-2583, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37052701
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Alemania